Please assess the completion status of the following clinical trial:

Trial Title: Ultrasound Guided Aspiration of Hydrosalpingeal Fluid and IVF-ET Outcomes

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with unilateral or bilateral hydrosalpinges visible by ultrasound~* Age between 18 - 37 years~* Period of infertility \> 1 year~* Body mass index between 19-29~* Normal basal luteinizing hormone (LH), follicle stimulating hormone (FSH) and prolactin concentrations~* Normal recent semen analysis (according to World Health Organization criteria)~Exclusion Criteria:~* Uterine fibroid requiring surgical removal~* Endometriosis~* Male factor of infertility requiring ICSI~* Previous IVF cycles~* History of recurrent miscarriage~* Endocrinologic disorders~* Presence of systemic disease contraindicating pregnancy

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 37 Years
- Healthy Volunteers: f

Study Arms:
- 1: Hydrosalpinx needle aspiration (Type: EXPERIMENTAL): After the retrieval of oocytes an aspiration needle is inserted into the hydrosalpinx under ultrasonographic guidance and suction is applied to aspirate the hydrosalpingeal fluid completely .
- 2. no aspiration (Type: NO_INTERVENTION): IVF-ET is done without prior aspiration of hydrosalpingeal fluid

Based on this trial design, predict the completion outcome and termination type (if applicable).